Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Ramat Gan
- Most recent report
- 6-K, filed Sep 9, 2026
- Filings on record
- 860 filings
- On EDGAR
- CIK 1536196
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 555
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 3, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 2, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 2, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 17, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 12, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 3, 2026
Prospectuses and Registrations 8 of 97
- F-3 Sep 25, 2026
- POS AM Post-effective amendment to a registration Sep 8, 2026
- POS AM Post-effective amendment to a registration Sep 8, 2026
- F-3 Aug 28, 2026
- 424B3 Prospectus supplement for an offering Apr 3, 2026
- F-3 Mar 31, 2026
- POS AM Post-effective amendment to a registration Mar 31, 2026
- POS AM Post-effective amendment to a registration Mar 31, 2026
Ownership 8 of 63
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
- 3 Insider reported their initial holding Apr 23, 2026
- 3 Insider reported their initial holding Apr 6, 2026
- 3 Insider reported their initial holding Mar 18, 2026
- 3 Insider reported their initial holding Mar 18, 2026
- 3 Insider reported their initial holding Mar 18, 2026
- 3 Insider reported their initial holding Mar 18, 2026
Other 8 of 145
- F-3/A Amended filing Sep 25, 2026
- EFFECT Notice that a registration became effective Sep 11, 2026
- EFFECT Notice that a registration became effective Sep 11, 2026
- D Sep 10, 2026
- EFFECT Notice that a registration became effective Apr 3, 2026
- CORRESP Reply to SEC staff Apr 1, 2026
- EFFECT Notice that a registration became effective Mar 31, 2026
- EFFECT Notice that a registration became effective Mar 31, 2026
Everything here comes from Can-Fite BioPharma Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.